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ABSTRACT 
Objectives: To evaluate the FIGO’s novel classification system versus the classic terminology in patients with abnormal 
uterine bleeding.
Material and methods: A retrospective study was carried out between August 2015 and September 2019 in the Health 
Sciences University Gazi Yaşargil Training and Research Hospital. The pathology reports of the patients were classified ac-
cording to the PALM-COEIN method and were compared with classical terminology. The operated patients with fibroids 
reported in the pathology results were classified as subgroups of fibroids.
Results: Evaluation was made of a total of 515 women with abnormal uterine bleeding. According to the classical terminol-
ogy, 137 (26.6%) patients were defined with hypermenorrhea, 74 (14.4%) with menorrhagia, 57 (11.1%) with metrorrhagia, 
and 246 (47.8%) with menometrorrhagia. In the PALM-COEIN classification system, polyps were determined in 84 (16.3%) 
cases, adenomyosis in 228 [diffuse adenomyosis:196 (38.1%), local adenomyosis:32 (6.2%)], leiomyoma in 386 [submu-
cous:161 (31.1%), other types: 225 (43.9%)], and malignancy and hyperplasia in 47 (9.1%).
Conclusions: The classical terminology for abnormal uterine bleeding is insufficient in terms of etiological pathologies 
in non-pregnant women of reproductive age. The widespread use of this novel system for the abnormal uterine bleeding 
classification will provide a more useful communication between physicians and researchers.
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INTRODUCTION
Abnormal uterine bleeding (AUB) is one of the most 
widespread gynecological symptoms as uterine hemor-
rhage which is different from normal menstruation in 
non-pregnant women of reproductive age [1]. The preva-
lence of AUB has been reported to be 11–15% in non-preg-
nant women of reproductive age [2].
A large number of terms are used to define the symp-
toms, signs and causes of AUB, like menorrhagia, metror-
rhagia, hypermenorrhea, menometrorrhagia, polymenor-
rhea and dysfunctional uterine bleeding. However, there 
has been an update to standardize descriptive terms, and 
menorrhagia, metrorrhagia, and oligomenorrhea have 
been replaced with the terminology of heavy menstrual 
bleeding (HMB), intermenstrual bleeding, and unscheduled 
bleeding or breakthrough bleeding with the use of hormone 
medication [3]. HMB is defined as an increase in the amount 
of menstrual bleeding that may affect physical, emotional 
and social quality of life. It can be objectively described by 
a drop in hemoglobin and the number of menstrual prod-
ucts used, such as tampons or pads per day [4].
This heterogeneity in the definitions of terminology, 
etiology and AUB causes confusion when comparing clinical 
treatment outcomes. Therefore, there has been seen to be 
a need for a standard, structured and consistent classifica-
tion for the underlying etiology of AUB. The development 
of a useful and universally accepted classification system 
for AUB has been remarkable for a long time, because the 
classical terminology defining AUB contains terms that are 
not related to a particular pathological process [5]. 
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As a result of these concerns, the International Federa-
tion of Gynecology and Obstetrics (FIGO) improved a novel 
classification system in 2011 to standardize AUB terminol-
ogy, management and diagnosis [6]. There are nine con-
siderable categories, which are adjusted according to the 
acronym: Polyp Adenomyosis Leiomyoma Malignancy and 
hyperplasia-Coagulopathy Ovulatory dysfunction Endome-
trial Iatrogenic Not yet classified. The “PALM” group includes 
structural pathologies that can be measured visually using 
imaging techniques or histopathology, while the “COEIN” 
group refers to non-structural pathologies that cannot be 
identified by imaging or histopathology.
The American College of Obstetricians and Gynecolo-
gists has proposed classifying AUB according to this novel 
system [1]. This system is a practical, consistent classification 
system designed for understanding and increasing knowl-
edge of AUB, and facilitating agreement between clinicians 
[7, 8]. A previous study identified several etiological factors 
responsible for AUB according to the PALM-COEIN classifi-
cation among women undergoing hysterectomy, and con-
cluded that this new classification is useful for comparative 
and epidemiological studies [9].
Even though some societies have established their own 
guidelines for the diagnosis and management of AUB ac-
cording to the novel this classification system, it is hard to 
classify AUB for patients with leiomyoma as outpatients in 
many low-income countries [10]. There has also been shown 
to be no clear terminology and consensus classification for 
adenomyosis, which is among the causes of AUB [11].
The aim of this study was to evaluate whether the FIGO 
PALM-COEIN classification system is more effective than clas-
sical terminology in patients with AUB. 
MATERIAL AND METHODS 
This cross-sectional study was conducted between 
August 2015 and September 2019 at the Health Sciences 
University Gazi Yaşargil Training and Research Hospital. A ret-
rospective evaluation was made of the files of patients who 
underwent surgeries such as hysterectomy, myomectomy 
and polypectomy due to AUB. Approval for the study was 
obtained from the Institutional Ethics Committee (Number: 
2019/348). Informed consent was not obtained from the 
patients due to the retrospective nature of the study.
A normal menstrual cycle was described as a period of 
24–38 days, lasting 4–8 days, with an average amount 
of bleeding of 35 mL and no significant changes from cycle 
to cycle as per FIGO guidelines. AUB was described as bleed-
ing from the uterine corpus that occurred with abnormal 
regularity, volume, frequency or duration when there is no 
pregnancy [12]. 
Patient with pregnancy-related bleeding, popstmeno-
pausal bleeding, cervix or lower genital system bleeding, 
suspected or diagnosed cervical carcinoma were excluded. 
Each patient was examined with physical examination and 
pelvic ultrasonography. Data were collected on patient 
age, parity, body mass index (BMI), and causes of AUB ac-
cording to classic terminology. In addition, analysis was 
performed to obtain reports of surgery and pathology 
results for structural pathologies that were then classified 
according to the PALM group. Adenomyosis was divided 
into local and diffuse subgroups. The size, number and 
location of fibroids obtained from the pathology results 
of the operated patients were recorded and classified as 
a subgroup.
Statistical analysis
All statistical analyses were performed using IBM SPSS 
20 software (IBM Corp. Released 2011. IBM SPSS Statistics 
for Windows, Version 20.0. Armonk, NY, USA). Descriptive 
statistics were stated as mean ± standard deviation (SD), 
minimum and maximum values, number (n) and percent-
age (%).
RESULTS
In this study period, 620 hysterectomies, 34 myomec-
tomies, and 36 polypectomies were performed for AUB. Of 
these, 515 women [465 (90.3%) hysterectomy, 24 (4.7%) 
myomectomy and 26 (5.0%) polypectomy] with appropriate 
data were determined and included. The distribution of all 
the patients diagnosed with AUB during the study period 
is summarized in Figure 1. 
The mean age of the patients was 46.3 ± 6.3 years, 
mean parity was 4.2 ± 1.6 and mean BMI was 29.4 ± 4.2. 
According to the classical terminology, 137 (26.6%) patients 
were diagnosed with hypermenorrhea, 74 (14.4%) with 
menorrhagia, 57 (11.1%) with metrorrhagia, 246 (47.8%) 
with menometrorrhagia. According to the PALM- 
-COEIN classification system, polyps were determined in 
84 (16.3%) cases, adenomyosis in 228 (44.3%) [diffuse ad-
enomyosis (AD) and local adenomyosis (AL)], leiomyoma 
in 386 (75%) [submucous leiomyoma (LSM) and others 
leiomyoma (LOT)], and malignancy and hyperplasia in 
47 (9.1%). 
Of the 137 patients with hypermenorrhea, a signifi-
cant part of these are leiomyoma, of the 74 patients with 
menorrhagia and of the 57 patients with metrorrhagia, 
a majority of these are leiomyoma, of the 247 patients 
with menometrorrhagia, a large part of these are leiomy-
oma and then adenomyosis according to the PALM-COEIN 
system (Tab. 1).
Overall, 386 patients underwent surgery for leimyoma, 
and according to the sub-classification, 65 (16.8%) of these 
had submucous myoma, and the remaining 321(83.2%) 
patients had other types of myoma (Tab. 2).
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Figure 1. Study flowchart; AUB — abnormal uterine bleeding; PALM-COEIN — Polyp Adenomyosis Leiomyoma Malignancy and hyperplasia-
Coagulopathy Ovulatory dysfunction Endometrial Iatrogenic Not yet classified; AL — local adenomyosis; AD — diffuse adenomyosis; LOT — others 
leiomyoma; LSM — submucous leiomyoma
Table 1. Comparison of cases according to classic terminology and the PALM-COEIN systema
PALM-COEIN system Hypermenorrhea  (n = 137)
Menorrhagia   
(n = 74)
Metrorrhagia
 (n = 57)
Menometrorrhagia
 (n = 247)
Polyp (n = 84) 23 (16.8) 12 (16.2) 10 (17.5) 39 (15.8)
Adenomyosis 
AL (n = 32)










   LSM (n = 161)










Hyperplasia (n = 47) 15 (10.9) 9 (12.2) 7 (12.3) 17 (6.9)
PALM-COEIN — Polyp Adenomyosis Leiomyoma Malignancy and hyperplasia-Coagulopathy Ovulatory dysfunction Endometrial Iatrogenic Not yet classified; AL — local 
adenomyosis; AD — diffuseadenomyosis; LOT — others leiomyoma; LSM — submucous leiomyoma; 
aValues are given as number (percentage)
DISCUSSION
This study was conducted to identify the reasons of AUB 
based on the PALM-COEIN classification and to compare 
the clinical and histopathological features to determine the 
definitive etiology for proper management of the AUB. As 
the clinical classification of AUB may result in inadequate 
treatment, there is a need for classification of the etiol-
ogy. In this study, the histopathological result of the hys-
terectomy specimen was accepted as the gold standard to 
evaluate the accuracy of the preoperative diagnosis of AUB 
causes. “Dysfunctional uterine bleeding (DUB)” is now a use-
less term as women classified in this category in the past 
in fact fall into the FIGO categories of a varying combina-
tion of coagulopathy, disorder of ovulation, or endometrial 
PALM-COEIN classification system of FIGO versus the classic 
terminology in patients with abnormal uterine bleeding
Excluded from analysis: (n = 175)
• Women with pregnancy — related bleeding
• Popstmenopausal bleeding
• Cervix bleeding
• Lower genital system bleeding
• Suspected or diagnosed cervical carcinoma
Patients included in the study 
(n = 515)
PALM-COEIN system 
n = 515 (100%)
Classic terminology 
n = 515 (100%)
Polyps, n = 84 (16.3%)
Adenomyosis, n = 228 (44.3%)
AL, n = 32 (6.2%)
An, n = l96 (38. l%)
Leiomyoma, n = 386 (75%) 
LSM, n = l61(3l. l%) 
LoT, n = 225 (43.9%)
Malignancy' and Hyperplasia,  
n = 47(9.1%)
Hypermenorrhea, n = 137 (26.6%) 
Menorrhagia, n = 74 (14.4%)
Metrorrhagia, n = 57 (11.1%)
Menometrorrhagia, n = 247 (47.8%)
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Table 2. Subclassification of leiomyomas by location  
Leiomyoma subclassification, n (%) n = 386 (100)
Submucosal
     0
     1





    3
    4
    5
    6
    7









aIncluded in both the endometrium and serosa
pathologies considered as “unrelated to uterine structural 
abnormalities” [13].
Obesity has been proven to be one of the leading caus-
es for AUB. Life-long exposure to estrogen by peripheral 
aromatization of adrenal androgens rises the incidence of 
polyps, leiomyomas and endometrial carcinomas in obese 
women (relative risk 3–10%) [14]. In the present study, the 
mean BMI of the patients was found to be in the overweight 
category. Therefore, care should be taken in terms of AUB 
in obese women.
Endometrial polyps are one of the most common etiolo-
gies of AUB in both premenopausal and postmenopausal 
women. Although they may also be asymptomatic, the 
part of polyps to AUB varies between 3.7% and 65 % [15]. 
Intermenstrual bleeding is the most frequent symptom 
in premenopausal women with endometrial polyps [16]. 
In the present study, 16.3% of women with AUB were found 
to have polyps and most had menometrorrhagia.
Uterine adenomyosis is a histological diagnosis based on 
the pathology evaluation of the uterus after hysterectomy. 
Preoperatively, the diagnosis is suggested by characteristic 
clinical manifestations (HMB and dysmenorrhea with a uni-
formly enlarged uterus), and a clinical diagnosis can be made 
with transvaginal ultrasound or magnetic resonance imaging 
findings. In some studies, the rate of adenomyosis as the 
cause of AUB has been reported as 14.5%–15.4% [13, 17]. 
In the present study, 44.3% of the women with AUB were 
found to have adenomyosis and most had menometror-
rhagia. The higher rate of adenomyosis compared to litera-
ture was attributed to the high parity of the current study 
patients.
Uterine leiomyomas (fibroids or myomas) are common 
benign tumors. The most common presenting symptoms 
of uterine fibroids are heavy or prolonged menstrual bleed-
ing. It was the most common cause of AUB followed by 
adenomyosis [13]. Myomas are clinically apparent in ap-
proximately 12–25% of reproductive-age women and are 
noted on pathological examination of approximately 80% 
of surgically excised uteri [18]. In a recent study of patients 
with AUB, 26.7% of fibroids were found to be submucosal 
[17]. The factor most contributing to bleeding in the PALM 
group is fibroids. In the present study, 75% of the patients 
had fibroids according to the pathology results and 16.8% 
were submucous myoma. It was observed that submucosal 
type caused more AUB compared to intramural and subse-
rous types [19]. It has been thought that submucous fibroids 
distort the cavity and are more likely to cause HMB [20]. 
In the current study, fibroids were classified into subgroups 
according to the PALM-COEIN classification.
The endometrium may develop endometrial hyperplasia, 
which includes non-neoplastic entities characterized by a pro-
liferation of endometrial glands of irregular size and shape, and 
precancerous neoplasms characterized by neoplastic features 
but without invasion. Endometrial hyperplasia and malignan-
cies typically present with AUB. Therefore, endometrial sam-
pling is still the primary diagnostic method for AUB. In the 
present study, endometrial hyperplasia was seen in 9.1% of 
cases, similar to the findings of the Mishra and Sultan study [21].
Treatment of acute AUB depends on many conditions, 
such as clinical stability, pain, suspected bleeding etiology, 
future fertility desire, and underlying medical issues. There 
are two basic purposes of managing acute AUB, firstly to 
control the current heavy bleeding attack and then to de-
crease blood loss during menstrual cycles. The preferred 
initial treatment is medical treatment, and hormonal man-
agement is the first application to be considered. There 
are treatment options such as IV conjugated estrogen, oral 
progestins and combined oral contraceptives. However, 
some conditions may require immediate surgical treatment. 
If we look at the surgical options for example dilatation and 
curettage, endometrial ablation, uterine artery embolization 
and hysterectomy can be considered [22].
CONCLUSIONS 
AUB is a complex condition because there are differenc-
es between individuals, so many pathologies accompany it. 
It can be considered that the use of the PALM-COEIN system 
will help eliminate confusion about the etiology of AUB and 
this diagnostic will enable more effective communication 
with other healthcare professionals, thereby resulting in 
better management of treatment.
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